CDC20 and cutaneous melanoma: In conclusion, we demonstrate that non-coding indels in the promoter of CDC20 reduce CDC20 expression, up-regulate genes associated with a more proliferative signature, and increase xenograft growth, supporting a putative cancer-driving role for the non-coding single nucleotide variants identified in 27.9% of skin cutaneous melanomas.